Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate

JJ McGuire, DJ Anderson and BM Bennett

Department of Pharmacology and Toxicology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada.

Recent studies suggest a role for the vascular cytochrome P450-NADPH cytochrome P450 reductase system in mediating the biotransformation of glyceryl trinitrate (GTN) to nitric oxide (or some closely related species), resulting in increased cyclic GMP accumulation and vasodilation. In this study we tested the effect of the flavoprotein inhibitor, diphenyleneiodonium sulfate (DPI) on GTN action in isolated rat aorta. Exposure of phenylephrine-contracted tissues to DPI (10 nM- 0.3 microM) resulted in 3- to 10-fold increases in the EC50 values for GTN-induced relaxation in both endothelium-intact tissues and endothelium-denuded tissues, whereas the vasodilator response to sodium nitroprusside was unaffected. Consistent with the relaxation data, cyclic GMP accumulation induced by 0.3 or 2 microM GTN was inhibited by 0.3 microM DPI in both endothelium-intact and endothelium-denuded aortic strips, whereas cyclic GMP accumulation induced by 0.1 microM sodium nitroprusside was unaffected. The regioselective formation of glyceryl-1,2-dinitrate observed during the aortic biotransformation of GTN was inhibited markedly by DPI. In tissues incubated with 0.3 or 10 microM DPI for 30 min followed by washout for 60 min, the EC50 values for GTN-induced relaxation were increased 2-fold, and both GTN-induced cyclic GMP accumulation and vascular GTN biotransformation were decreased. This suggests an irreversible component to the inhibitory action of DPI. Together, these data provide evidence for the involvement of a flavoprotein (e.g., NADPH cytochrome P450 reductase) in the metabolic activation of GTN required for expression of its vasodilator activity.

Volume 271, Issue 2, pp. 708-714, 11/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Li, X. Liu, H. Cui, Y.-R. Chen, A. J. Cardounel, and J. L. Zweier Characterization of the Mechanism of Cytochrome P450 Reductase-Cytochrome P450-mediated Nitric Oxide and Nitrosothiol Generation from Organic Nitrates J. Biol. Chem., May 5, 2006; 281(18): 12546 - 12554. [Abstract] [Full Text] [PDF]

				B. J. Day and C. Kariya A Novel Class of Cytochrome P450 Reductase Redox Cyclers: Cationic Manganoporphyrins Toxicol. Sci., May 1, 2005; 85(1): 713 - 719. [Abstract] [Full Text] [PDF]

				H. Li, H. Cui, X. Liu, and J. L. Zweier Xanthine Oxidase Catalyzes Anaerobic Transformation of Organic Nitrates to Nitric Oxide and Nitrosothiols: CHARACTERIZATION OF THIS MECHANISM AND THE LINK BETWEEN ORGANIC NITRATE AND GUANYLYL CYCLASE ACTIVATION J. Biol. Chem., April 29, 2005; 280(17): 16594 - 16600. [Abstract] [Full Text] [PDF]

				J. DiFabio, Y. Ji, V. Vasiliou, G. R. J. Thatcher, and B. M. Bennett Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance Mol. Pharmacol., November 1, 2003; 64(5): 1109 - 1116. [Abstract] [Full Text] [PDF]

				J. D. Ratz, A. B. Fraser, K. J. Rees-Milton, M. A. Adams, and B. M. Bennett Endothelin Receptor Antagonism Does Not Prevent the Development of In Vivo Glyceryl Trinitrate Tolerance in the Rat J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 578 - 585. [Abstract] [Full Text]

				J. D. Ratz, J. J. McGuire, D. J. Anderson, and B. M. Bennett Effects of the Flavoprotein Inhibitor, Diphenyleneiodonium Sulfate, on Ex Vivo Organic Nitrate Tolerance in the Rat J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 569 - 577. [Abstract] [Full Text]

				P. S.-Y. Wong and J. M. Fukuto Reaction of Organic Nitrate Esters and S-Nitrosothiols With Reduced Flavins: A Possible Mechanism of Bioactivation Drug Metab. Dispos., April 1, 1999; 27(4): 502 - 509. [Abstract] [Full Text]

				R. Yuan, M. Sumi, and L. Z. Benet J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1499 - 1505. [Abstract]